Tue, Nov. 1, 3:32 AM
- A surge of blockbuster takeovers and buyouts has provided renewed ammunition for the corporate bond market, supplying fresh kindling in what is already set to be a record year of debt issuance.
- The backlog of M&A that had yet to be financed slid to $246B at the end of September from more than $900B in late 2015, according to BofA Merrill Lynch, but that figure has climbed 87% to $460B following the recent string of deal announcements.
- ETFs: LQD, VCSH, VCIT, VCLT, CORP, CSJ, CIU, CSI, CRED, IGI, LWC, SCPB, CLY, ITR, BSCH, IGHG, QLTA, BSCG, BSCI, BSCK, BSCJ, IBCE, SLQD, LQDH, COBO, FCOR, IBCC, IBDC, CBND, BSCL, BSCO, IBDD, IBDF, IBDB, IBDH, LDRI, IBDQ, SKOR, BSCM, BSCN, BSCP, IBCD, IBDN, IGIH, BSCQ, IBDK, IBDM, CLYH, IBDJ, IBDL, IBDO, IBDP, IBDR, SFIG, WFIG
Feb. 15, 2013, 11:58 AM
IGI Laboratories (IG +2.2%) trades up after signing a three-year agreement with Juventio LLC to manufacture and supply finished dose forms of certain cosmetic and OTC products and formulations owned and developed by IGI. The products utilize encapsulation technology trademarked as Novasome for which the company currently holds an exclusive license.| Feb. 15, 2013, 11:58 AM
Nov. 16, 2012, 3:44 PM